NAD+ is the coenzyme that powers every cell in your body — from energy production and DNA repair to the sirtuin proteins most linked to how fast you age. The problem is that by your 50s, NAD+ levels have dropped by roughly half from their peak. The effects hit hardest where you feel them most: your energy, your focus, your mental sharpness.
NAD+ Nasal Spray is formulated to reach the brain efficiently by traveling through the olfactory nerve pathway — a direct neurological route that bypasses the digestive system entirely. No needles. No injections. One spray, once or twice daily.
For patients who want NAD+ targeted toward cognitive function and daily mental clarity, the nasal spray delivers a convenient, needle-free option that fits into any morning routine.
Includes ongoing provider care & support
Compounded medication · Platform access
Declining NAD+ doesn't just slow your body down. It changes how your brain runs. These are the figures worth knowing.
Individual results vary. Olfactory delivery data reflects research on intranasal compounds generally; specific NAD+ brain uptake via intranasal route has been studied in animal models and is an active area of human research. NAD+ Nasal Spray is a compounded preparation used off-label for longevity and cognitive wellness. Results are not guaranteed.
Intranasal delivery uses one of the body's oldest and most direct pathways — the olfactory nerve — to move compounds from the nasal cavity toward the brain without passing through the gastrointestinal tract.
A single spray is applied to the nasal mucosa — the highly vascular tissue lining your nasal cavity, rich in nerve endings and capillaries.
The compound absorbs rapidly through the nasal mucosa. This bypasses the digestive system and avoids first-pass metabolism in the liver — the process that degrades much of what you swallow.
The olfactory nerve runs directly from the nasal cavity to the brain. Intranasal compounds travel along this route toward the olfactory bulb and from there into surrounding brain structures.
Delivery via the olfactory pathway can reach central nervous system tissue in approximately 20 minutes — without passing through the blood-brain barrier as a limiting step.
Both deliver NAD+. The right choice depends on your goals — and many patients use both.
Brain-targeted • Needle-free
Systemic • Highest bioavailability
The spray handles daily cognitive support and brain-targeted delivery. The injection handles full-body NAD+ saturation — energy production, metabolic support, DNA repair. Used together, they complement each other without overlap. Your care team can recommend the right protocol for your goals.
Your body encodes seven sirtuin proteins — SIRT1 through SIRT7 — that regulate aging pathways, inflammation, and metabolic function. Every one of them requires NAD+ as a co-substrate to work. Without adequate NAD+, sirtuin activity declines sharply with age. Restoring NAD+ levels reactivates these longevity enzymes.
NAD+ is the central electron carrier in the mitochondrial electron transport chain — the process your cells use to generate ATP, the molecule that powers nearly every biological function. As NAD+ falls, mitochondria become less efficient. The result is the fatigue, mental sluggishness, and slow recovery that accumulate with age.
PARP enzymes are your body's first responders for DNA damage — and they consume NAD+ to function. Each repair event depletes cellular NAD+. Maintaining adequate levels ensures PARP enzymes have the fuel they need to keep up with daily DNA strand breaks, protecting genomic stability over time.
NAD+ nasal spray is generally well-tolerated. Here is what most patients experience.
NAD+ Nasal Spray is generally well-tolerated across the patient populations using it. The most commonly reported effects are mild nasal irritation or a brief burning sensation upon application — typically transient and self-resolving. Most patients notice no adverse effects with regular use.
Results build over time with consistent use. Some patients notice improved mental clarity or energy within the first few weeks. Cognitive and longevity-related benefits associated with NAD+ restoration — including improved mitochondrial function and sirtuin activity — tend to compound over months of consistent use.
Reach out to your Obsidian Genetics provider if you experience persistent nasal discomfort, unexpected symptoms, or have questions about dosing. Your care team monitors your response and can adjust your protocol based on how you're doing.
All Obsidian Genetics prescriptions are issued by licensed providers following a clinical intake review. Your provider reviews your health history, goals, and current medications before prescribing. NAD+ Nasal Spray is not appropriate for everyone — your provider will determine whether it is right for you.
Pricing
One flat rate. Physician supervision, compounded medication, and ongoing support included.
Pricing to be announced at launch.
All plans include: physician consultation · compounded medication · ongoing provider support · free shipping
Compounded Medication Notice: NAD+ Nasal Spray is a compounded preparation. It is not an FDA-approved drug product. Compounded medications are not reviewed by the FDA for safety, efficacy, or manufacturing standards. This product is prescribed by a licensed provider and prepared by a licensed compounding pharmacy for individual patient use. It is intended for off-label wellness and longevity purposes. Results are not guaranteed and individual outcomes vary.
Not Medical Advice: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before starting any new treatment. All Obsidian Genetics prescriptions are issued following a clinical review by a licensed provider.
Citations & Evidence: Statistical claims on this page are sourced from peer-reviewed literature as referenced. Olfactory delivery data reflects established research on intranasal compounds generally (PMC7836101, Journal of Clinical Trials). NAD+ brain delivery via intranasal route is supported by animal models and mechanistic research; controlled human trials are ongoing. NAD+ decline: Rajman, Chwalek & Sinclair, Cell Metabolism (2018). Sirtuins: Imai & Guarente, Trends in Cell Biology (2014); PMC9797940. Cell count: Bianconi et al., Annals of Human Biology (2013).
NAD+ is a trademark reference to nicotinamide adenine dinucleotide, a naturally occurring coenzyme. Obsidian Genetics is a telehealth platform connecting patients with licensed providers. ©2024 Obsidian Genetics. All rights reserved.